Malignant Uterine Corpus Neoplasm — Trials

Malignant Uterine Corpus Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,571 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 411
Recruiting: 226
Ph III recruiting: 25
Growth YoY: +3.1%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.6%
Trials / 1,000 deaths: 50.2 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (168)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07065552	Tirzepatide in Obesity-Driven Endometrial Cancer	recruiting	Early Phase 1	20	UNC Lineberger Comprehensive Cancer CenterOTHER	1	Sep 11, 2026	clinicaltrials
NCT05691010	A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer	recruiting	Early Phase 1	28	Memorial Sloan Kettering Cancer CenterOTHER	1	Jun 25, 2026	clinicaltrials